Hikma Pharmaceuticals PLC (LON:HIK - Get Free Report) insider Victoria Hull sold 2,777 shares of the company's stock in a transaction on Tuesday, April 8th. The shares were sold at an average price of GBX 1,800 ($23.00), for a total value of £49,986 ($63,871.71).
Hikma Pharmaceuticals Trading Up 2.6 %
Shares of LON HIK opened at GBX 1,841 ($23.52) on Wednesday. The company has a current ratio of 1.66, a quick ratio of 1.27 and a debt-to-equity ratio of 55.82. The company has a market cap of £5.11 billion, a PE ratio of 18.07, a P/E/G ratio of 2.38 and a beta of 0.41. The company has a 50-day moving average of GBX 2,132.90 and a two-hundred day moving average of GBX 2,014.91. Hikma Pharmaceuticals PLC has a 1-year low of GBX 1,750 ($22.36) and a 1-year high of GBX 2,360 ($30.16).
Hikma Pharmaceuticals Increases Dividend
The company also recently disclosed a dividend, which will be paid on Thursday, May 1st. Shareholders of record on Thursday, March 20th will be given a $0.48 dividend. This represents a yield of 1.8%. This is a positive change from Hikma Pharmaceuticals's previous dividend of $0.32. The ex-dividend date of this dividend is Thursday, March 20th. Hikma Pharmaceuticals's dividend payout ratio (DPR) is presently 60.84%.
Analyst Ratings Changes
A number of brokerages recently issued reports on HIK. JPMorgan Chase & Co. reiterated an "overweight" rating on shares of Hikma Pharmaceuticals in a research report on Friday, March 7th. Berenberg Bank reissued a "buy" rating and issued a GBX 2,560 ($32.71) target price on shares of Hikma Pharmaceuticals in a report on Monday, March 10th.
Check Out Our Latest Stock Report on HIK
Hikma Pharmaceuticals Company Profile
(
Get Free Report)
At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
